Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-1049-2014

Drug recall · February 5, 2014

Soliris recall

Why: Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6.

Lots / codes

Lot #: 10001-1, Exp 07/14; 10010A, Exp 10/15

Quantity
21,661 vials
Company
Alexion Pharmaceuticals, Inc., Cheshire, CT
Distribution
Nationwide, Puerto Rico, Jamaica, and Grenada.
Initiated
November 4, 2013 · Voluntary: Firm initiated
Classified
January 30, 2014
Reported
February 5, 2014
Ended
March 2, 2015
How notified
E-Mail

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.